- Home
- MED vs KRRO Comparison
MED vs KRRO Comparison
Compare MED & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MED | KRRO |
|---|---|---|
| Founded | 1980 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 120.6M | 101.1M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | MED | KRRO |
|---|---|---|
| Price | $11.36 | $12.57 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 12 |
| Target Price | $16.50 | ★ $54.60 |
| AVG Volume (30 Days) | 224.0K | ★ 295.4K |
| Earning Date | 02-17-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $429,695,000.00 | $7,371,000.00 |
| Revenue This Year | N/A | $145.49 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $470.77 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.10 | $5.20 |
| 52 Week High | $16.66 | $55.89 |
Technical Indicators
Market Signals| Indicator | MED | KRRO |
|---|---|---|
| Relative Strength Index (RSI) | 40.44 | 57.82 |
| Support Level | $10.81 | $11.33 |
| Resistance Level | $11.31 | $14.94 |
| Average True Range (ATR) | 0.43 | 1.07 |
| MACD | -0.09 | 0.18 |
| Stochastic Oscillator | 0.75 | 52.75 |
Price Performance
Historical ComparisonAbout MED MEDIFAST INC
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.